Cancel
Prof. Dr. Ekkehard Schütz
Chief Science Officer
@
OncoCyte
xqq.5j7jf994.jxg343@984g19xl.308
Sign up to see email
Known information
- Joined Oncocyte in April 2021 through the acquisition of Chronix Biomedical
- Serves as the managing director of Chronix Biomedical GmbH, wholly owned by Oncocyte and CMO for Europe
- Teaches molecular genetics and diagnostics at the Georg-August-University
- Received training in laboratory medicine at the Dept. of Clinical Chemistry in the hospital of the Georg-August-University of Göttingen from 1989 to 2001
- Joined Chronix Biomedical Inc. in 2001 and established its German subsidiary in 2002 as the R&D site of the company
- Elected as a fellow of the National Academy for Clinical Biochemistry, which became the Academy of the American Association for Clinical Chemistry (FAACC) in 2014
- Has published over 170 peer-reviewed publications and book chapters
- Has over 100 published congress abstracts
- Received several international scientific awards
- Serves as a reviewer for numerous international scientific journals, including PNAS, Clin Chem, Clin Biochem and NAR
About OncoCyte
OncoCyte specializes in oncology and transplant diagnostic solutions, offering products like DetermaCNI, DetermaIO, VitaGraft Kidney, and VitaGraft Liver, alongside biopharma services to enhance patient care.
Report inaccurate information
